Trump administration advances plan for peptide drugs favoured by RFK Jr.

Trump administration advances plan for peptide drugs favoured by RFK Jr. left The panel of outside experts that met in July was selected by Kennedy’s health department and included several doctors, pharmacists and consultants who work in the peptide field |Image used for representational purpose only Getty Images/iStockphoto Getty Images/iStockphoto https://th-i.thgim.com/public/incoming/j7gx1t/article71592666.ece/alternates/FREE_1200/CCI_UDHindu_KSL_UBG450N03_R1528561514_0_628d5e11-8c28-44d6-99dd-be49d9e48347.jpg selvanegra The beta amyloid peptid consists of about 30 amino acids. It aggregates to amyloid plaques, that may damage and kill neurons by generating reactive oxygen species during its elf-aggregation. Federal health officials are moving ahead with plans to broaden access to a class of unproven injectable drugs called peptides WASHINGTON (AP) — U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides, a class of largely unregulated injections that have become popular among followers of Health Secretary Robert F. Kennedy Jr. and other wellness influencers.